KT
ACOR

Kanaly Trust’s Acorda Therapeutics ACOR Stock Holding History

Kanaly Trust’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2
Closed -$5K – 929
2015
Q3 		$5K Hold
2
– – ﹤0.01% 657
2015
Q2 		$7K Hold
2
– – ﹤0.01% 601
2015
Q1 		$7K Hold
2
– – ﹤0.01% 496
2014
Q4 		$8K Hold
2
– – ﹤0.01% 494
2014
Q3 		$7K Hold
2
– – ﹤0.01% 509
2014
Q2 		$7K Hold
2
– – ﹤0.01% 516
2014
Q1 		$8K Hold
2
– – ﹤0.01% 533
2013
Q4 		$6K Buy
+2
New +$7.8K ﹤0.01% 504

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kanaly Trust's ACOR Position: Q4 2015 in Review

Kanaly Trust sold out of Acorda Therapeutics (ACOR) in Q4 2015, closing a stake of 2 shares — an estimated $5K sold.

Kanaly Trust first reported a position in ACOR in Q4 2013 and held it in 8 quarters. The position peaked at $8K in Q4 2014. 186 funds tracked by Wall St. Rank hold ACOR as of Q4 2015.

  • Kanaly Trust reported no remaining Acorda Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Kanaly Trust sold 2 Acorda Therapeutics shares in Q4 2015, an estimated $5K.
  • Kanaly Trust first reported a position in Acorda Therapeutics in Q4 2013 and held it in 8 quarters.
  • Kanaly Trust's Acorda Therapeutics position peaked at $8K in Q4 2014.
  • 186 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2015.

Based on Kanaly Trust's 13F filing for Q4 2015, filed 25 Jan 2016.